Topical immunomodulation in the treatment of herpetic infections in HIV-infected patients

Eksperimental'naya i Klinicheskaya Farmakologiya

Volumn 75, Issue 11, 2012, Pages 35-37

  Shul'Dyakov, A A ^a   Barkhatova, T S ^a   Zubareva, E V ^a   Satarova, S A ^a   Perminova, T A ^a  

^a SARATOV STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Cycloferon; Herpes; HIV

Indexed keywords

CYCLOFERON; IMMUNOMODULATING AGENT; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; EPITHELIZATION; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; LINIMENT; RASH; RELAPSE; TREATMENT DURATION;

ACRIDINES; ADMINISTRATION, TOPICAL; ADULT; COINFECTION; DRUG THERAPY, COMBINATION; FEMALE; HERPES SIMPLEX; HERPESVIRIDAE; HIV; HIV INFECTIONS; HUMANS; IMMUNOLOGIC FACTORS; LINIMENTS; MALE; VIRUS LATENCY;

EID: 84872398721     PISSN: 08692092     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. C. Birek, G. Ficarra, Current Infectious Disease Reports, No 8, P. 181-188 (2006).
2. D. Eisen, Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod., No 86, 432-437 (1998).